MEASuRE: Metreleptin Effectiveness And Safety Registry

ClinicalTrials.gov ID: NCT02325674

Public ClinicalTrials.gov record NCT02325674. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Sep 6, 2026, 4:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study is a post-authorization, prospective, voluntary registry of patients treated with commercial metreleptin including, but not limited to, patients in the US and EEA.

Study identification

NCT ID: NCT02325674
Recruitment status: Recruiting
Study type: Observational
Phase: Not listed
Lead sponsor: Chiesi Farmaceutici S.p.A.; Industry
Enrollment: 100 participants

Conditions and interventions

Conditions

Interventions

Metreleptin Drug

Drug

Eligibility (public fields only)

Age range: Not listed
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Oct 10, 2016
Primary completion: Oct 30, 2031
Completion: Oct 30, 2031
Last update posted: Jul 15, 2026

2016 – 2031

United States locations

U.S. sites: 16
U.S. states: 13
U.S. cities: 14

Facility	City	State	ZIP	Site status
University Alabama at Birmingham	Birmingham	Alabama	40506	Terminated
City of Hope	Duarte	California	91010	Terminated
Atlanta Diabetes Associates	Atlanta	Georgia	30318	Completed
Ann & Robert H. Lurie Children's Hospital of Chicago	Chicago	Illinois	60611	Recruiting
University of Kansas Medical Center Research Institute, Inc.	Kansas City	Kansas	66160	Recruiting
Children's Hospital of New Orleans/LSU Health Sciences Center	New Orleans	Louisiana	70118	Completed
Ochsner Clinic Foundation	New Orleans	Louisiana	70121	Withdrawn
Nih/Niddk/Deob	Bethesda	Maryland	20892	Recruiting
University of Michigan	Ann Arbor	Michigan	48109	Recruiting
Childrens Hospital of Michigan	Detroit	Michigan	48201	Recruiting
Richmond University Medical Centre	Staten Island	New York	10314	Completed
Endocrinology Research Associates	Columbus	Ohio	43201	Recruiting
Children's Hospital of Philadelphia	Philadelphia	Pennsylvania	19104	Recruiting
University of Pennsylvania	Philadelphia	Pennsylvania	19104	Withdrawn
UT Southwestern Medical Center	Dallas	Texas	75390	Recruiting
Seattle Children's Hospital	Seattle	Washington	98105	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02325674, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jul 15, 2026 · Synced Sep 6, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02325674 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →